You are here

Prevnar 13

FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game

FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game

Endpoints

breakthrough status

Flag link:

Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3

Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3

Fierce Pharma

pneumococcal disease

Flag link:

Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way

Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way

Fierce Pharma

Flag link:

Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

Fierce Pharma

Flag link:

Pneumonia vaccine triples protection in animal models

Pneumonia vaccine triples protection in animal models

Fierce Biotech

antibiotic resistance

Flag link:

Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates

Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates

Fierce Pharma

Flag link:

Top 25 vaccine products in 2016, based on U.S. sales

Top 25 vaccine products in 2016, based on U.S. sales

Medical Marketing and Media

Flag link:

Pfizer Wins Indian Patent on Prevnar 13 Vaccine

Pfizer Wins Indian Patent on Prevnar 13 Vaccine

RAPS.org

Flag link:

SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines

SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines

Endpoints

pneumococcal disease

Flag link:

Pfizer Has Strong Track Record since 2010

Pfizer Has Strong Track Record since 2010

Market Realist

Flag link:

Pfizer offers cut-price pneumonia shot for humanitarian crises

Pfizer offers cut-price pneumonia shot for humanitarian crises

Yahoo/Reuters

Flag link:

Interesting Trend Developing for Pfizer’s Pneumococcal Franchise

Interesting Trend Developing for Pfizer’s Pneumococcal Franchise

Market Realist

pneumococcal disease

Flag link:

Hillary’s Gift to Big Pharma

Hillary’s Gift to Big Pharma

WSJ Online

Hillary Clinton

2016 Presidential election

Flag link:

Will Pfizer (PFE) Stock Be Affected by Pneumonia Vaccine Approval?

Will Pfizer (PFE) Stock Be Affected by Pneumonia Vaccine Approval?

TheStreet.com

Flag link:

Pfizer is expanding its vaccine portfolio, developing others

Pfizer is expanding its vaccine portfolio, developing others

Yahoo/AP

Flag link:

Pfizer Inc. Wins European Commission Approval For New Prevenar 13 Indication

Pfizer Inc. Wins European Commission Approval For New Prevenar 13 Indication

Bidness Etc.

Flag link:

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln

Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln

Yahoo/Reuters

Flag link:

Does Pfizer still need AstraZeneca's vaccines business?

Does Pfizer still need AstraZeneca's vaccines business?

Fierce Vaccines

Flag link:

Endorsement could boost Pfizer vax

Endorsement could boost Pfizer vax

Medical Marketing and Media

Flag link:

U.S. advisory panel recommends Prevnar 13 vaccine for elderly

U.S. advisory panel recommends Prevnar 13 vaccine for elderly

Reuters

advisory panels

Flag link:

Pages